Evidence map›Paper›PMID 31598848›Full record

ArticleEndocrine2020

Clinicopathological correlations of mesenteric fibrosis and evaluation of a novel biomarker for fibrosis detection in small bowel neuroendocrine neoplasms.

Faidon-Marios Laskaratos, Dalvinder Mandair, Andrew Hall, Sarah Alexander, Conrad von Stempel, Josephine Bretherton, TuVinh Luong, Jennifer Watkins, Olagunju Ogunbiyi, Krista Rombouts and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Endocrine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Transcriptomic Profiling ofFrontiers in oncology · 2021
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Faidon-Marios LaskaratosNeuroendocrine Tumour Unit, Centre for Gastroenterology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust and University College London, London, UK. flaskaratos@gmail.com.
Dalvinder MandairNeuroendocrine Tumour Unit, Centre for Gastroenterology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust and University College London, London, UK.
Andrew HallDepartment of Cellular Pathology, Royal Free London NHS Foundation Trust, London, UK.
Sarah AlexanderDepartment of Cellular Pathology, Royal Free London NHS Foundation Trust, London, UK.
Conrad von StempelDepartment of Radiology, Royal Free London NHS Foundation Trust, London, UK.
Josephine BrethertonDepartment of Radiology, Royal Free London NHS Foundation Trust, London, UK.
TuVinh LuongDepartment of Cellular Pathology, Royal Free London NHS Foundation Trust, London, UK.
Jennifer WatkinsDepartment of Cellular Pathology, Royal Free London NHS Foundation Trust, London, UK.
Olagunju OgunbiyiDepartment of Colorectal Surgery, Royal Free London NHS Foundation Trust, London, UK.
Krista RomboutsRegenerative Medicine & Fibrosis Group, Institute for Liver and Digestive Health, Division of Medicine, University College London, London, UK.
Martyn CaplinNeuroendocrine Tumour Unit, Centre for Gastroenterology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust and University College London, London, UK.
Christos ToumpanakisNeuroendocrine Tumour Unit, Centre for Gastroenterology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust and University College London, London, UK.
Royal Free London NHS Foundation Trust · GBUniversity College London · GB

Funding

Royal Free Charity N/A
6 · The paper itself

Abstract

purposeMesenteric fibrosis (MF) in small intestinal neuroendocrine neoplasms (SINENs) is often associated with significant morbidity and mortality. The detection of MF is usually based on radiological criteria, but no previous studies have attempted a prospective, multidimensional assessment of mesenteric desmoplasia to determine the accuracy of radiological measurements. There is also a lack of non-invasive biomarkers for the detection of image-negative MF.

methodsA multidimensional assessment of MF incorporating radiological, surgical and histological parameters was performed in a prospective cohort of 34 patients with SINENs who underwent primary resection. Pre-operative blood samples were collected in 20 cases to evaluate a set of five profibrotic circulating transcripts-the "fibrosome"-that is included as an "omic" component of the NETest.

resultsThere was a significant correlation between radiological and surgical assessments of MF (p < 0.05). However, there were several cases of image-negative MF. The NETest-fibrosome demonstrated an accuracy of 100% for the detection of microscopic MF.

conclusionsThe detection of MF by radiological criteria has limitations. The NETest-fibrosome is a promising biomarker for fibrosis detection and further validation of these results would be needed in larger, multicentre studies.

Indexed as

Intestinal NeoplasmsNeuroendocrine TumorsBiomarkers, TumorFibrosisHumansProspective StudiesBiomarkers, TumorBiomarkerFibrosisNETestNeuroendocrine tumour

Identifiers

PMID31598848
PMCPMC7054371
OpenAlexW2980190675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.